Active enhancers are delineated de novo during hematopoiesis, with limited lineage fidelity among specified primary blood cells.
about
Enhancer repertoires are reshaped independently of early priming and heterochromatin dynamics during B cell differentiationHigh-dimensional genomic data bias correction and data integration using MANCIENF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytesPioneer factors govern super-enhancer dynamics in stem cell plasticity and lineage choice.Sorting Out Identities: An Educational Primer for Use with "Novel Tools for Genetic Manipulation of Follicle Stem Cells in the Drosophila Ovary Reveal an Integrin-Dependent Transition from Quiescence to Proliferation".The Yin and Yang of Chromatin Dynamics In Stem Cell Fate SelectionDevelopmental Control of NRAMP1 (SLC11A1) Expression in Professional PhagocytesDistinct functions of histone H3, lysine 4 methyltransferases in normal and malignant hematopoiesis.Transcriptional, epigenetic and retroviral signatures identify regulatory regions involved in hematopoietic lineage commitment.Transcriptional Control of Stem and Progenitor PotentialThe roles of SNF2/SWI2 nucleosome remodeling enzymes in blood cell differentiation and leukemiaLineage specific transcription factors and epigenetic regulators mediate TGFβ-dependent enhancer activation.A UTX-MLL4-p300 Transcriptional Regulatory Network Coordinately Shapes Active Enhancer Landscapes for Eliciting Transcription.
P2860
Q28607796-C8BB2E8E-D8DD-45DE-88BA-06D7622C8993Q31075558-00454A8B-94B3-459F-9F4B-28C006B89486Q33434134-D289C607-FF05-496D-A969-4604E89C835BQ34468207-A3BF8ABD-9863-4A16-87A1-1A545F0B58B8Q36050066-94B98328-4596-479D-A8D1-BE55E0C2A5DAQ36522743-73F828CC-58DE-4FFE-802C-14C202BC98A5Q38807143-06DA47CB-BD04-4BDC-BE7D-7486625FC2A3Q38855791-94E266C6-C329-4568-9DEE-84D054D46A96Q40370482-9E30EB8F-E418-4A5E-B788-FBAD1069D7F3Q40384669-DE9FFA57-77A9-4D9A-BDD4-09578F20C95AQ41194172-B37C3177-DB7B-4BD1-A3B3-64E5A797ADC6Q50041523-C882A365-6A24-4005-B20C-2D23FF266BC9Q50877542-3C6ACF8F-DC05-4E8B-B52F-7E4C47B561A7
P2860
Active enhancers are delineated de novo during hematopoiesis, with limited lineage fidelity among specified primary blood cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Active enhancers are delineate ...... specified primary blood cells.
@ast
Active enhancers are delineate ...... specified primary blood cells.
@en
Active enhancers are delineate ...... specified primary blood cells.
@nl
type
label
Active enhancers are delineate ...... specified primary blood cells.
@ast
Active enhancers are delineate ...... specified primary blood cells.
@en
Active enhancers are delineate ...... specified primary blood cells.
@nl
prefLabel
Active enhancers are delineate ...... specified primary blood cells.
@ast
Active enhancers are delineate ...... specified primary blood cells.
@en
Active enhancers are delineate ...... specified primary blood cells.
@nl
P2093
P2860
P356
P1433
P1476
Active enhancers are delineate ...... specified primary blood cells.
@en
P2093
Annouck Luyten
Ramesh A Shivdasani
X Shirley Liu
P2860
P304
P356
10.1101/GAD.240101.114
P577
2014-08-01T00:00:00Z